Oxford Biomedica Plc Ord 50P is listed on the London Stock Exchange trading with ticker code OXB.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £44,858m, with approximately 66m shares in issue.
Oxford Biomedica Plc, officially known as Oxford Biomedica Plc Ord 50P was formed in September of 1996, making the company twenty three years old. The company filed its latest accounts on 31st December 2014, showing a turnover of approximately 13.62 million GBX with gross profits of 9.20 million, or 0.1392 per issued share, and a pre-tax profit margin of -79.29%. Oxford Biomedica Plc currently has 8 directors, and has had 19 previous directors over the last 23 years. In the last set of accounts produced by Pricewaterhousecoopers Llp, the company showed 7.93 million paid in salaries to the 113 staff (average wage of 70 thousand), with the directors receiving an average 204 thousand each. In the accounts filed in 2014, the company paid 0 in dividends. These accounts also showed Oxford Biomedica Plc to have a net worth of 20.93 million, with 14.20 million held in cash.
Oxford Biomedica Plc is in the Medicine and Biotech Research sector.
Oxford Biomedica Plc is in the MID 300 index.
|Sinclair Pharma Plc (SPH.L)|
|Proteome Sciences Plc (PRM.L)|
|Summit Therapeutics Plc (SUMM.L)|
|Eco Animal Health Group Plc (EAH.L)|
|Vp Plc (VP..L)|
|Shares in Issue||66m|
|52 Week High||0.00|
|52 Week Low||0.00|